| Authors: |
Heger JM; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf, University of Cologne, Medical Faculty and University Hospital Cologne, Cologne, Germany.; Cancer Center Cologne Essen-Partner Site Cologne, CIO Cologne, University of Cologne, Cologne, Germany.; Cologne Lymphoma Working Group, Cologne, Germany.; Mildred Scheel School of Oncology Aachen Bonn Cologne Düsseldorf and Faculty of Medicine and University Hospital Cologne, Cologne, Germany.; German Hodgkin Study Group, Cologne, Germany., Mattlener J; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf, University of Cologne, Medical Faculty and University Hospital Cologne, Cologne, Germany.; Cancer Center Cologne Essen-Partner Site Cologne, CIO Cologne, University of Cologne, Cologne, Germany.; German Hodgkin Study Group, Cologne, Germany., Kaul H; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf, University of Cologne, Medical Faculty and University Hospital Cologne, Cologne, Germany.; German Hodgkin Study Group, Cologne, Germany., Ferdinandus J; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf, University of Cologne, Medical Faculty and University Hospital Cologne, Cologne, Germany.; Cancer Center Cologne Essen-Partner Site Cologne, CIO Cologne, University of Cologne, Cologne, Germany.; German Hodgkin Study Group, Cologne, Germany., Schneider J; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf, University of Cologne, Medical Faculty and University Hospital Cologne, Cologne, Germany.; Cancer Center Cologne Essen-Partner Site Cologne, CIO Cologne, University of Cologne, Cologne, Germany., Schleifenbaum JK; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf, University of Cologne, Medical Faculty and University Hospital Cologne, Cologne, Germany.; Cancer Center Cologne Essen-Partner Site Cologne, CIO Cologne, University of Cologne, Cologne, Germany.; Cologne Lymphoma Working Group, Cologne, Germany., Schneider G; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf, University of Cologne, Medical Faculty and University Hospital Cologne, Cologne, Germany.; German Hodgkin Study Group, Cologne, Germany., Schaub V; Department II of Internal Medicine, University of Tübingen, Tübingen, Germany., Hänel M; Department III of Internal Medicine, Klinikum Chemnitz, Chemnitz, Germany., Hellmuth JC; Department of Medicine III, Ludwig Maximilian University Hospital Munich, Munich, Germany., Dierlamm J; University Hospital Hamburg-Eppendorf, Hamburg, Germany., Martin S; Department of Hematology and Oncology, Robert Bosch Hospital, Stuttgart, Germany., Mathas S; Hematology, Oncology, and Cancer Immunology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Berlin, Germany.; Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Biology of Malignant Lymphomas, Berlin, Germany.; Experimental and Clinical Research Center, a joint cooperation between Charité and Max Delbrück Center, Berlin, Germany., Meissner J; Hematology, Oncology and Rheumatology, Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany., Pegtel DM; Cancer Center Amsterdam, Imaging and Biomarkers and Department of Pathology, Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., Zijlstra JM; Department of Hematology, Amsterdam University Medical Center, Cancer Center Amsterdam and HOVON Imaging Working Group, Amsterdam, The Netherlands., Ossowski A; West German Genome Center and Cologne Center for Genomics, Medical Faculty, University of Cologne, Cologne, Germany., Becker K; West German Genome Center and Cologne Center for Genomics, Medical Faculty, University of Cologne, Cologne, Germany., Hallek M; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf, University of Cologne, Medical Faculty and University Hospital Cologne, Cologne, Germany.; Cancer Center Cologne Essen-Partner Site Cologne, CIO Cologne, University of Cologne, Cologne, Germany., von Tresckow B; German Hodgkin Study Group, Cologne, Germany.; Department of Hematology and Stem Cell Transplantation, University Hospital Essen, University of Duisburg-Essen, German Cancer Consortium (Partner Site Essen), Essen, Germany.; Cancer Center Cologne Essen-Partner Site Essen, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany., Borchmann P; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf, University of Cologne, Medical Faculty and University Hospital Cologne, Cologne, Germany.; Cancer Center Cologne Essen-Partner Site Cologne, CIO Cologne, University of Cologne, Cologne, Germany.; Cologne Lymphoma Working Group, Cologne, Germany.; German Hodgkin Study Group, Cologne, Germany., Borchmann S; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf, University of Cologne, Medical Faculty and University Hospital Cologne, Cologne, Germany.; Cancer Center Cologne Essen-Partner Site Cologne, CIO Cologne, University of Cologne, Cologne, Germany.; Cologne Lymphoma Working Group, Cologne, Germany.; German Hodgkin Study Group, Cologne, Germany.; Liqomics GmbH, Cologne, Germany. |
